2179 — Jiangsu Recbio Technology Co Balance Sheet
0.000.00%
- HK$2.53bn
- HK$2.86bn
- CNY12.73m
Annual balance sheet for Jiangsu Recbio Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,183 | 1,325 | 912 | 448 | 352 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 51.9 | 12.6 | 38.6 | 93.9 | 0.665 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,295 | 1,420 | 1,129 | 655 | 538 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 511 | 814 | 1,003 | 1,162 | 1,052 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,919 | 2,310 | 2,186 | 1,940 | 1,762 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 139 | 329 | 444 | 839 | 538 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 246 | 648 | 1,115 | 1,411 | 1,056 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 1,673 | 1,662 | 1,071 | 529 | 706 |
| Total Liabilities & Shareholders' Equity | 1,919 | 2,310 | 2,186 | 1,940 | 1,762 |
| Total Common Shares Outstanding |